BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 4, 2008
View Archived Issues
Novel plant-derived vaccine found safe and immunogenic in lymphoma patients
Read More
Efalizumab shows efficacy in the treatment of head and neck psoriasis
Read More
Pfizer's PF-3084014 effectively reduces Abeta levels in guinea pigs and mice
Read More
Novel fluorene compounds neutralize Abeta-oligomer toxicity in preclinical studies
Read More
Upregulation of Hsp70 by KU-32 leads to a reduction of Tau phosphorylation in mice
Read More
Mayo Clinic initiates dosing in phase Ib clinical study of Nile's CD-NP in heart failure
Read More
Bristol-Myers proposes to acquire ImClone Systems
Read More
Novel NS5B polymerase inhibitors described in recent patents
Read More
Novel oncolytic agents reported in patent literature
Read More
Upstream and Makerere University to collaborate on animal testing of Leishmaniasis treatment
Read More
Seattle Genetics commences phase I trial for SGN-70 in healthy volunteers
Read More
FDA issues not approvable letter to Schering-Plough for sugammadex
Read More
FDA grants orphan drug designation to afamelanotide in erythropoietic porphyrias
Read More
E.U. grants approval to Actelion's Tracleer in mildly symptomatic PAH
Read More
Karo Bio reports positive results from phase IIb study with eprotirome in dyslipidemia
Read More
Labopharm launches once-daily tramadol in South Korea, Australia, Romania and Austria
Read More
Aegera initiates dosing in phase I/II clinical oncology study of AEG-35156
Read More
BioMS completes enrollment in phase III MAESTRO-03 clinical trial of dirucotide
Read More
FDA awards RegeneRx additional USD 136,000 for phase II trial of RGN-137 in EB
Read More
Gilead and Merck & Co. sign agreement for HIV medication Atripla in 12 countries
Read More
PYY(3-36) for obesity does not meet primary efficacy endpoint in phase II study
Read More
Wyeth reviews Q2 highlights
Read More
Patents reveal discovery of compounds for metabolic disorders
Read More